News

Published on 11 Apr 2024 on Bloomberg via Yahoo Finance

Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer


Article preview image

(Bloomberg) -- Vertex Pharmaceuticals Inc. agreed to buy Alpine Immune Sciences Inc. for a total equity value of about $4.9 billion, adding the biotech company’s immune treatments in its biggest acquisition ever.

Most Read from Bloomberg

US Sees Imminent Missile Strike on Israel by Iran, ProxiesVietnam Tycoon Lan Sentenced to Death Over $12 Billion FraudUS Slams Strikes on Russia Oil Refineries as Risk to Oil MarketsRussia Destroys Largest Power Plant in Ukraine’s Kyiv RegionApple Plans to Overhaul Entire Mac Line With AI-Focused M4 Chips

NASDAQ.CRSP price evolution
NASDAQ.VERA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb...

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? P...

Benzinga 16 Feb 2025

Why CRISPR Therapeutics (CRSP) Soared on Friday?

We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going ...

Insider Monkey · via Yahoo Finance 15 Feb 2025

NHS Rolls Out £1.7 Million Gene Therapy for Sickle Cell Disease

(Bloomberg) -- One of the world’s most expensive medicines will be used to treat some patients wi...

Bloomberg · via Yahoo News 31 Jan 2025

Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going t...

Insider Monkey · via Yahoo Finance 31 Jan 2025

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being hig...

Zacks · via Yahoo Finance 23 Jan 2025

RFK Jr. earned millions from law work, book deals

HHS Secretary designate Robert F. Kennedy Jr. earned $326,000 from the anti-vaccine group Childre...

Axios 23 Jan 2025

RFK Jr. Profited From Lawsuits Against Agency He’s Poised to Lead

(Bloomberg) -- Robert F. Kennedy Jr. earned millions from his work as an attorney, including...

Bloomberg · via Yahoo News 23 Jan 2025

CRISPR Therapeutics stock pops following disclosure of RFK Jr. investment

A financial disclosure form from HHS Secretary nominee Robert F. Kennedy, Jr., indicated a stake ...

Seeking Alpha 23 Jan 2025

RFK Jr. reports up to $1.2M in credit card debt, $30M net worth

From a multimillion-dollar law firm payout to six-figure endorsements and book deals, President...

ABC News 23 Jan 2025

RFK Jr. reports up to $1.2M in credit card debt, $30M net worth

From a multimillion-dollar law firm payout to six-figure endorsements and book deals, President...

ABC News · via Yahoo Finance 23 Jan 2025